NCT02245828View on ClinicalTrials.gov

A First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of QCC374

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Healthy Subjects
Interventions
DRUG

QCC374

Single and multiple ascending doses of QCC374

DRUG

Placebo

Placebo comparator

Trial Locations (1)

CF484DR

Novartis Investigative Site, Mid Glamorgan

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY